Notably, the US FDA submission documents for tirzepatide include predictions of DDIs mediated by delayed gastric emptying using PBPK modeling, rather than conducting clinical DDI studies for certain drugs (Table 6)
What Is This Compound
After an application by plaintiffs to organize the case in a Multidistrict Litigation (MDL), the two largest defendants, Novo Nordisk and Eli Lilly, are split on their response to the application
Early results from the REDEFINE-4 trial showed that participants lost an average of 22.7% of their body weight, making it a potential competitor to existing treatments
For example, in the treatment of cancer cachexia, some clinical trials are evaluating the effectiveness of combination therapy with other anti-cancer drugs, hoping to provide more effective treatment options for cancer patients
Who is looking out for customers